Frankfurt - Delayed Quote EUR
TG Therapeutics, Inc. (NKB2.F)
35.26
+0.90
+(2.63%)
At close: April 25 at 8:06:17 AM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-40,517
-40,517
-31,413
-176,170
-295,634
Investing Cash Flow
-1,036
-1,036
-50,651
-20,013
-332
Financing Cash Flow
128,527
128,527
72,705
-391
41,419
End Cash Position
181,192
181,192
94,218
103,577
300,151
Income Tax Paid Supplemental Data
500
500
--
--
--
Interest Paid Supplemental Data
18,470
18,470
8,771
5,445
3,466
Capital Expenditure
-45
-45
--
-14
-401
Issuance of Capital Stock
--
--
46,296
--
2,219
Issuance of Debt
244,815
244,815
25,000
--
70,000
Repayment of Debt
-107,553
-107,553
--
-975
-30,000
Repurchase of Capital Stock
-8,760
-8,760
--
--
--
Free Cash Flow
-40,562
-40,562
-31,413
-176,184
-296,035
12/31/2021 - 10/23/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
10VA.F Immunic, Inc.
0.9870
+3.89%
FTD.SG Financière de Tubize SA
116.20
+1.40%
DR6.F ACADIA Pharmaceuticals Inc.
13.03
+2.04%
MDG1.F Medigene AG
0.1485
-1.00%
ICY.F Incyte Corporation
51.80
+1.81%
PRTC.L PureTech Health plc
125.60
-1.72%
TUB.BR Financière de Tubize SA
118.40
+1.72%
22UA.DE BioNTech SE
102.10
-0.10%
TNFA TNF Pharmaceuticals, Inc.
0.2200
+14.58%
RARE Ultragenyx Pharmaceutical Inc.
38.09
+1.20%